Biography and Research Information
OverviewAI-generated summary
Alexx Weaver's research has focused on the molecular mechanisms underlying disease, particularly leishmaniasis and breast cancer. Weaver has investigated the role of enhanced translational activity in lymphatic endothelial cell activation in cutaneous leishmaniasis, a parasitic disease transmitted by sandflies. This work has involved studying disease models in animals and exploring potential therapeutic compounds. Weaver's publications also include investigations into the anticancer effects of plant-derived compounds, such as arachidin-1 and stilbene-rich extracts, in combination with paclitaxel for triple-negative and hormone receptor-positive breast cancer cells. These studies explore how these compounds enhance the efficacy of chemotherapy and elucidate their mechanisms of action. Weaver collaborates with researchers at the University of Arkansas for Medical Sciences, including Hayden Roys, Anne K. Bowlin, and Lucy Fry, as well as Fabricio Medina-Bolívar at Arkansas State University.
Metrics
- h-index: 2
- Publications: 10
- Citations: 15
Selected Publications
-
Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267 (2025)
-
Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis (2025)
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
-
Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis (2024)
-
Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids (2024)
-
Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells (2023)
-
Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells (2022)
-
Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer (2022)
Collaboration Network
Top Collaborators
Sepideh Mohammadhosseinpour
Arkansas State University (US)
5 shared publications
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids
Lucy Fry
University of Arkansas for Medical Sciences
4 shared publications
In database
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267
Hayden Roys
University of Arkansas for Medical Sciences
4 shared publications
In database
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267
Anne K. Bowlin
University of Arkansas for Medical Sciences
4 shared publications
In database
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267
Tiffany Weinkopff
University of Arkansas for Medical Sciences
4 shared publications
In database
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267
Linh‐Chi Ho
3 shared publications
In database
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
Fabricio Medina-Bolívar
Arkansas State University
3 shared publications
In database
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Abstract 2653: Arachidin-1 Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
- Stilbene-rich extract increases the cytotoxic effects of paclitaxel in hormone receptor-positive and triple-negative breast cancer spheroids
Jordan T. Bird
University of Arkansas for Medical Sciences (US)
3 shared publications
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis 4267
Fabricio Medina‐ Bolivar
Arkansas State University
2 shared publications
In database
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
Gopinath Venugopal
University of Arkansas for Medical Sciences (US)
2 shared publications
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
Stephanie D. Byrum
Arkansas Children's Hospital
2 shared publications
In database
- Enhanced translational activity is linked to lymphatic endothelial cell activation in cutaneous leishmaniasis
- Enhanced Translational Activity Is Linked to Lymphatic Endothelial Cell Activation in Cutaneous Leishmaniasis
Sophia McLain
1 shared publication
- A Link Between Components of the Nasal Microbiome and an Individual’s Susceptibility to Influenza.
Whitney M. Holden
1 shared publication
- A Link Between Components of the Nasal Microbiome and an Individual’s Susceptibility to Influenza.
Meenakshi Sudhakaran
Michigan State University (US)
1 shared publication
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
Tra Le
Arkansas Biosciences Institute
1 shared publication
In database
- Arachidin-1, a Prenylated Stilbenoid from Peanut, Enhances the Anticancer Effects of Paclitaxel in Triple-Negative Breast Cancer Cells
Similar Researchers
Based on overlapping research topics
Alexei G. Basnakian
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Microbial infections and disease research
Cancer Treatment and Pharmacology
Suman Kumar Samanta
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Jing-Fu Jenq
University of Arkansas at Fayetteville
Disease Mechanisms Research
Microbial infections and disease research
Host-Pathogen Interactions
Paul D. Adams
University of Arkansas at Fayetteville
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research
Drug Delivery Systems
Yejin Kim
University of Arkansas for Medical Sciences
Microbial infections and disease research
Cancer-related molecular mechanisms research
Phytochemicals and Antioxidant Activities
Alicja Urbaniak
University of Arkansas for Medical Sciences
Disease Mechanisms Research
Cancer Treatment and Pharmacology
Cancer-related molecular mechanisms research